Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-19

Clinical Trial Update: Efficacy of Myo-inositol in Preventing Gestational Diabetes in High-risk Pregnant Women [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of myo-inositol to prevent gestational diabetes mellitus in high-risk pregnant women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Myo-inositol (myo-inositol)

Snippet

Sponsor: AGUNCO Obstetrics and Gynecology Centre | Conditions: Gestational Diabetes | Phase 4 | Status: UNKNOWN